MedPath

Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

Not Applicable
Not yet recruiting
Conditions
Enhanced Recovery After Surgery
Length of Hospital Stay
Prostate Cancer
Prehabilitation
Prostatectomy
Interventions
Procedure: ERAS management pathway
Procedure: Routine care
Registration Number
NCT05576766
Lead Sponsor
Peking University First Hospital
Brief Summary

Prostate cancer ranks second among all malignances in men and has become a significant threat to men's health. Robot-assisted laparoscopic radical prostatectomy (RARP) has become a standard treatment for prostate cancer. How to improve recovery following RARP surgery is worth investigating. The enhanced recovery after surgery (ERAS) pathway involves a series of evidence-based procedures. It is aimed to reduce the systemic stress response to surgery and shorten the length of hospital stay. This randomized trial aims to investigate the impact of Enhanced Recovery After Surgery (ERAS) Pathway on early outcomes after RARP surgery.

Detailed Description

Prostate cancer ranks second among all malignancies in men and has become a significant threat to men's health. Surgical resection is the main treatment for patients with early and locally advanced prostate cancer. With the progress of technology, robot-assisted laparoscopic radical prostatectomy (RARP) is gradually accepted by surgeons and become the first line treatment for prostate cancer. How to improve recovery after RARP surgery is worth investigating.

The concept of enhanced recovery after surgery (ERAS) was first reported by Dr. Kehlet. The ERAS pathway involves a series of evidence-based managements to accelerate patients' rehabilitation, including selective bowel preparation, nutritional therapy, fluid management, multimodal analgesia, early mobilization, etc. It has been applied to many patient populations including those undergoing gastrointestinal surgery, cardiothoracic surgery, and urological surgery. Previous studies showed that practicing ERAS in patients undergoing laparoscopic prostate surgery shortened the time to flatus and defecate and the length of hospital stay. Specifically, prehabilitation including aerobic exercise and pelvic floor training may be beneficial and improve physical wellbeing in patients undergoing prostatectomy. However, little is known regarding the effects of ERAS in patients undergoing RARP surgery.

The purpose of this randomized controlled trial is to investigate the impact of ERAS management, including prehabilitation, on early outcomes in patients undergoing RARP surgery.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
90
Inclusion Criteria
  • Aged 60 years or over but below 90 years.
  • Scheduled to undergo robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer.
  • Agree to participate in this study and give written informed consent.
Exclusion Criteria
  • Scheduled to undergo combined surgery, including RARP combined with pelvic lymph node dissection or other procedures.
  • American Society of Anesthesiologists (ASA) physical classification ≥IV.
  • Inability to receive preoperative aerobic exercise because of severe cardiovascular disease, motor system diseases (arthritis, lumbar vertebrae disease), or central nervous system diseases (epilepsy, parkinsonism).
  • Inability to communicate in the preoperative period because of profound dementia, deafness, or language barriers.
  • History of schizophrenia, anxiety or depressive disorders, or other mental disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ERAS groupERAS management pathwayPerioperative management according to the Enhanced Recovery after Surgery (ERAS) pathway.
Routine care groupRoutine carePerioperative management according to routine care.
Primary Outcome Measures
NameTimeMethod
Length of stay in hospitalUp to 30 days after surgery

Length of stay in hospital of the first hospitalization.

Secondary Outcome Measures
NameTimeMethod
Total hospitalization cost within 30 days after surgeryUp to 30 days after surgery

Total hospitalization cost is defined as the sum cost of hospitalization from admission up to 30 days after surgery, including re-hospitalization within 30 days.

Incidence of postoperative complications within 30 days after surgeryUp to 30 days after surgery

Postoperative complications are defined as new-onset medical events that are harmful to patients' recovery and required therapeutic intervention, that is grade II or higher on the Clavien-Dindo classification.

Perioperative anxiety scoreOn the day before surgery and at day 1 after surgery.

The score of anxiety is assessed by using the Self-Rating Anxiety Scale (SAS). This is a 20-item self-report questionnaire; each item is rated from 1 to 4 denoting the increasing severity or frequency of anxiety; the sum score times 1.25 as a standard score, ranging from 25 to 100, with higher score indicating more severe anxiety.

Incidence of readmission within 30 days after surgeryUp to 30 days after surgery

Readmission is defined as hospitalization for the second time after discharge within 30 days after surgery.

Perioperative depression scoreOn the day before surgery and at day 1 after surgery.

The score of depression is assessed by using the Self-Rating Depression Scale (SDS). This is a 20-item self-report questionnaire; each item is rated from 1 to 4 denoting the increasing severity or frequency of depression; the sum score times 1.25 as a standard score, ranging from 25 to 100, with higher score indicating more severe depression.

Pain score within 3 days after surgeryUp to 3 days after surgery

Pain score is assessed twice daily (8:00-10:00 am, and 18:00-20:00 pm) with the Numeric Rating Scale (NRS), an 11-point scale ranging from 0 to 10, with 0=no pain and 10=the worst pain.

Overall survival within 90 days after surgeryUp to 90 days after surgery

Overall survival within 90 days after surgery.

Trial Locations

Locations (1)

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath